-
1
-
-
24044515511
-
Treatment of severe coagulopathy after gunshot injury to the head using recombinant activated factor VII
-
Aiyagari, V., Menendez, J. A., & Diringer, M. N. (2005). Treatment of severe coagulopathy after gunshot injury to the head using recombinant activated factor VII. Journal of Critical Care, 20(2), 176-179.
-
(2005)
Journal of Critical Care
, vol.20
, Issue.2
, pp. 176-179
-
-
Aiyagari, V.1
Menendez, J.A.2
Diringer, M.N.3
-
2
-
-
24644491444
-
Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials
-
discussion 15-18
-
Boffard, K. D., Riou, B., Warren, B., Choong, P. I., Rizoli, S., Rossaint, R., et al. (2005). Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials. Journal of Trauma, 59(1), 8-15; discussion 15-18.
-
(2005)
Journal of Trauma
, vol.59
, Issue.1
, pp. 8-15
-
-
Boffard, K.D.1
Riou, B.2
Warren, B.3
Choong, P.I.4
Rizoli, S.5
Rossaint, R.6
-
3
-
-
29544443813
-
The use of recombinant activated factor VII in trauma-associated hemorrhage with crush injury
-
Christians, K., Brasel, K., Garlitz, J., Abu-Hajir, M., & Gottschall, J. (2005). The use of recombinant activated factor VII in trauma-associated hemorrhage with crush injury. Journal of Trauma, 59(3), 742-746.
-
(2005)
Journal of Trauma
, vol.59
, Issue.3
, pp. 742-746
-
-
Christians, K.1
Brasel, K.2
Garlitz, J.3
Abu-Hajir, M.4
Gottschall, J.5
-
4
-
-
0030908865
-
Predicting life-threatening coagulopathy in the massively transfused trauma patient: Hypothermia and acidosis revisited
-
discussion 861-852
-
Cosgriff, N., Moore, E. E., Sauaia, A., Kenny-Moynihan, M., Burch, J. M., & Galloway, B. (1997). Predicting life-threatening coagulopathy in the massively transfused trauma patient: Hypothermia and acidosis revisited. Journal of Trauma, 42(5), 857-861; discussion 861-852.
-
(1997)
Journal of Trauma
, vol.42
, Issue.5
, pp. 857-861
-
-
Cosgriff, N.1
Moore, E.E.2
Sauaia, A.3
Kenny-Moynihan, M.4
Burch, J.M.5
Galloway, B.6
-
5
-
-
0037016029
-
Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate
-
Deveras, R. A., & Kessler, C. M. (2002). Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Annals of Internal Medicine, 137(11), 884-888.
-
(2002)
Annals of Internal Medicine
, vol.137
, Issue.11
, pp. 884-888
-
-
Deveras, R.A.1
Kessler, C.M.2
-
6
-
-
7244221863
-
Factor VIIa for correction of traumatic coagulopathy
-
discussion 718-719
-
Dutton, R. P., McCunn, M., Hyder, M., D'Angelo, M., O'Connor, J., Hess, J. R., et al. (2004). Factor VIIa for correction of traumatic coagulopathy. Journal of Trauma, 57(4), 709-718; discussion 718-719.
-
(2004)
Journal of Trauma
, vol.57
, Issue.4
, pp. 709-718
-
-
Dutton, R.P.1
McCunn, M.2
Hyder, M.3
D'Angelo, M.4
O'Connor, J.5
Hess, J.R.6
-
7
-
-
0034123683
-
Hypothermia, coagulopathy, and acidosis
-
Eddy, V. A., Morris, J. A., Jr., & Cullinane, D. C. (2000). Hypothermia, coagulopathy, and acidosis. Surgical Clinics of North America, 80(3), 845-854.
-
(2000)
Surgical Clinics of North America
, vol.80
, Issue.3
, pp. 845-854
-
-
Eddy, V.A.1
Morris Jr., J.A.2
Cullinane, D.C.3
-
8
-
-
0032465250
-
The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0
-
Erhardtsen, E., Nony, P., Dechavanne, M., Ffrench, P., Boissel, J. P., & Hedner, U. (1998). The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0. Blood Coagulation and Fibrinolysis, 9(8), 741-748.
-
(1998)
Blood Coagulation and Fibrinolysis
, vol.9
, Issue.8
, pp. 741-748
-
-
Erhardtsen, E.1
Nony, P.2
Dechavanne, M.3
Ffrench, P.4
Boissel, J.P.5
Hedner, U.6
-
9
-
-
14744286988
-
The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage in blunt trauma
-
Geeraedts, L. M., Jr., Kamphuisen, P. W., Kaasjager, H. A., Verwiel, J. M., van Vugt, A. B., & Frolke, J. P. (2005). The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage in blunt trauma. Injury, 36(4), 495-500.
-
(2005)
Injury
, vol.36
, Issue.4
, pp. 495-500
-
-
Geeraedts Jr., L.M.1
Kamphuisen, P.W.2
Kaasjager, H.A.3
Verwiel, J.M.4
van Vugt, A.B.5
Frolke, J.P.6
-
10
-
-
0035083870
-
Trauma critical care
-
Gentilello, L. M., & Pierson, D. J. (2001). Trauma critical care. American Journal of Respiratory and Critical Care Medicine, 163(3, Pt. 1), 604-607.
-
(2001)
American Journal of Respiratory and Critical Care Medicine
, vol.163
, Issue.3 and PART. 1
, pp. 604-607
-
-
Gentilello, L.M.1
Pierson, D.J.2
-
11
-
-
33646487022
-
Mechanism of action of factor VIIa in the treatment of coagulopathies
-
Hedner, U. (2006). Mechanism of action of factor VIIa in the treatment of coagulopathies. Seminars in Thrombosis and Hemostasis, 32(Suppl. 1), 77-85.
-
(2006)
Seminars in Thrombosis and Hemostasis
, vol.32
, Issue.SUPPL. 1
, pp. 77-85
-
-
Hedner, U.1
-
12
-
-
0036083721
-
Decision making in perioperative transfusion
-
Isbister, J. P. (2002). Decision making in perioperative transfusion. Transfusion and Apheresis Science, 27(1), 19-28.
-
(2002)
Transfusion and Apheresis Science
, vol.27
, Issue.1
, pp. 19-28
-
-
Isbister, J.P.1
-
13
-
-
0036302232
-
Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy
-
Jeffers, L., Chalasani, N., Balart, L., Pyrsopoulos, N., & Erhardtsen, E. (2002). Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy. Gastroenterology, 123(1), 118-126.
-
(2002)
Gastroenterology
, vol.123
, Issue.1
, pp. 118-126
-
-
Jeffers, L.1
Chalasani, N.2
Balart, L.3
Pyrsopoulos, N.4
Erhardtsen, E.5
-
14
-
-
0027981345
-
Functional equivalence of hypothermia to specific clotting factor deficiencies
-
Johnston, T. D., Chen, Y., & Reed, R. L., II. (1994). Functional equivalence of hypothermia to specific clotting factor deficiencies. Journal of Trauma, 37(3), 413-417.
-
(1994)
Journal of Trauma
, vol.37
, Issue.3
, pp. 413-417
-
-
Johnston, T.D.1
Chen, Y.2
Reed II, R.L.3
-
15
-
-
0033610715
-
Treatment of traumatic bleeding with recombinant factor VIIa
-
Kenet, G., Walden, R., Eldad, A., & Martinowitz, U. (1999). Treatment of traumatic bleeding with recombinant factor VIIa. Lancet, 354(9193), 1879.
-
(1999)
Lancet
, vol.354
, Issue.9193
, pp. 1879
-
-
Kenet, G.1
Walden, R.2
Eldad, A.3
Martinowitz, U.4
-
16
-
-
3142557734
-
Successful use of activated recombinant factor VII in traumatic liver injuries in children
-
Kulkarni, R., Daneshmand, A., Guertin, S., Fath, J., Atwal, M., Melvin, J., et al. (2004). Successful use of activated recombinant factor VII in traumatic liver injuries in children. Journal of Trauma, 56(6), 1348-1352.
-
(2004)
Journal of Trauma
, vol.56
, Issue.6
, pp. 1348-1352
-
-
Kulkarni, R.1
Daneshmand, A.2
Guertin, S.3
Fath, J.4
Atwal, M.5
Melvin, J.6
-
17
-
-
17644372011
-
Recombinant factor VIIa in the treatment of non-hemophiliac bleeding
-
Lam, M. S., & Sims-McCallum, R. P. (2005). Recombinant factor VIIa in the treatment of non-hemophiliac bleeding. Annals of Pharmacotherapy, 39(5), 885-891.
-
(2005)
Annals of Pharmacotherapy
, vol.39
, Issue.5
, pp. 885-891
-
-
Lam, M.S.1
Sims-McCallum, R.P.2
-
18
-
-
17044405174
-
Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review
-
Levi, M., Peters, M., & Buller, H. R. (2005). Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review. Critical Care Medicine, 33(4), 883-890.
-
(2005)
Critical Care Medicine
, vol.33
, Issue.4
, pp. 883-890
-
-
Levi, M.1
Peters, M.2
Buller, H.R.3
-
19
-
-
31444437882
-
Massive transfusion coagulopathy
-
Levy, J. H. (2006). Massive transfusion coagulopathy. Seminars in Hematology, 43(1, Suppl. 1), S59-S63.
-
(2006)
Seminars in Hematology
, vol.43
, Issue.1 and SUPPL. 1
-
-
Levy, J.H.1
-
20
-
-
21444452237
-
Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: A report by the Israeli Multidisciplinary rFVIIa Task Force
-
Martinowitz, U., & Michaelson, M. (2005). Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: A report by the Israeli Multidisciplinary rFVIIa Task Force. Journal of Thrombosis and Haemostasis, 3(4), 640-648.
-
(2005)
Journal of Thrombosis and Haemostasis
, vol.3
, Issue.4
, pp. 640-648
-
-
Martinowitz, U.1
Michaelson, M.2
-
21
-
-
11144246729
-
Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage
-
Mayer, S. A., Brun, N. C., Broderick, J., Davis, S., Diringer, M. N., Skolnick, B. E., et al. (2005). Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke, 36(1), 74-79.
-
(2005)
Stroke
, vol.36
, Issue.1
, pp. 74-79
-
-
Mayer, S.A.1
Brun, N.C.2
Broderick, J.3
Davis, S.4
Diringer, M.N.5
Skolnick, B.E.6
-
22
-
-
0348163468
-
The effect of temperature and pH on the activity of factor VIIa: Implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients
-
Meng, Z. H., Wolberg, A. S., Monroe, D. M., III, & Hoffman, M. (2003). The effect of temperature and pH on the activity of factor VIIa: Implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. Journal of Trauma, 55(5), 886-891.
-
(2003)
Journal of Trauma
, vol.55
, Issue.5
, pp. 886-891
-
-
Meng, Z.H.1
Wolberg, A.S.2
Monroe III, D.M.3
Hoffman, M.4
-
23
-
-
33645815503
-
A critical appraisal of the use of recombinant factor VIIa in acquired bleeding conditions
-
Mittal, S., & Watson, H. G. (2006). A critical appraisal of the use of recombinant factor VIIa in acquired bleeding conditions. British Journal of Haematology, 133(4), 355-363.
-
(2006)
British Journal of Haematology
, vol.133
, Issue.4
, pp. 355-363
-
-
Mittal, S.1
Watson, H.G.2
-
24
-
-
30944461398
-
Thromboembolic adverse events after use of recombinant human coagulation factor VIIa
-
O'Connell, K. A., Wood, J. J., Wise, R. P., Lozier, J. N., & Braun, M. M. (2006). Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. Journal of the American Medical Association, 295(3), 293-298.
-
(2006)
Journal of the American Medical Association
, vol.295
, Issue.3
, pp. 293-298
-
-
O'Connell, K.A.1
Wood, J.J.2
Wise, R.P.3
Lozier, J.N.4
Braun, M.M.5
-
25
-
-
0036185754
-
Successful use of recombinant activated factor VII for trauma-associated hemorrhage in a patient without preexisting coagulopathy
-
O'Neill, P. A., Bluth, M., Gloster, E. S., Wali, D., Priovolos, S., DiMaio, T. M., et al. (2002). Successful use of recombinant activated factor VII for trauma-associated hemorrhage in a patient without preexisting coagulopathy. Journal of Trauma, 52(2), 400-405.
-
(2002)
Journal of Trauma
, vol.52
, Issue.2
, pp. 400-405
-
-
O'Neill, P.A.1
Bluth, M.2
Gloster, E.S.3
Wali, D.4
Priovolos, S.5
DiMaio, T.M.6
-
26
-
-
14944382685
-
FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: A report of four cases
-
Pavese, P., Bonadona, A., Beaubien, J., Labrecque, P., Pernod, G., Letoublon, C., et al. (2005). FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: A report of four cases. Canadian Journal of Anaesthesia, 52(1), 26-29.
-
(2005)
Canadian Journal of Anaesthesia
, vol.52
, Issue.1
, pp. 26-29
-
-
Pavese, P.1
Bonadona, A.2
Beaubien, J.3
Labrecque, P.4
Pernod, G.5
Letoublon, C.6
-
27
-
-
0004148928
-
-
2nd ed, Philadelphia: Lippincott Williams & Wilkins
-
Peitzman, A. B., Rhodes, M., Schwab, C. W., Yealy, D. M., & Fabian, T. C. (2002). The Trauma Manual (2nd ed.). Philadelphia: Lippincott Williams & Wilkins.
-
(2002)
The Trauma Manual
-
-
Peitzman, A.B.1
Rhodes, M.2
Schwab, C.W.3
Yealy, D.M.4
Fabian, T.C.5
-
28
-
-
18144393811
-
Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: A double-blind, randomized, placebo-controlled trial
-
Raobaikady, R., Redman, J., Ball, J. A., Maloney, G., & Grounds, R. M. (2005). Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: A double-blind, randomized, placebo-controlled trial. British Journal of Anaesthesia, 94(5), 586-591.
-
(2005)
British Journal of Anaesthesia
, vol.94
, Issue.5
, pp. 586-591
-
-
Raobaikady, R.1
Redman, J.2
Ball, J.A.3
Maloney, G.4
Grounds, R.M.5
-
29
-
-
0842277796
-
Safety profile of recombinant factor VIIa
-
Roberts, H. R., Monroe, D. M., III, & Hoffman, M. (2004). Safety profile of recombinant factor VIIa. Seminars in Hematology, 41(1, Suppl. 1), 101-108.
-
(2004)
Seminars in Hematology
, vol.41
, Issue.1 and SUPPL. 1
, pp. 101-108
-
-
Roberts, H.R.1
Monroe III, D.M.2
Hoffman, M.3
-
30
-
-
0028909841
-
Epidemiology of trauma deaths: A reassessment
-
Sauaia, A., Moore, F. A., Moore, E. E., Moser, K. S., Brennan, R., Read, R. A., et al. (1995). Epidemiology of trauma deaths: A reassessment. Journal of Trauma, 38(2), 185-193.
-
(1995)
Journal of Trauma
, vol.38
, Issue.2
, pp. 185-193
-
-
Sauaia, A.1
Moore, F.A.2
Moore, E.E.3
Moser, K.S.4
Brennan, R.5
Read, R.A.6
-
31
-
-
33745095308
-
Role of recombinant activated factor VII in securing haemostatic failure in gun shot trauma
-
Shamsi, T., Tufail, M., Aftab, M., & Ansari, S. (2006). Role of recombinant activated factor VII in securing haemostatic failure in gun shot trauma. Journal of the Pakistan Medical Association, 56(5), 238-241.
-
(2006)
Journal of the Pakistan Medical Association
, vol.56
, Issue.5
, pp. 238-241
-
-
Shamsi, T.1
Tufail, M.2
Aftab, M.3
Ansari, S.4
-
32
-
-
0842342597
-
Emerging risks and outcomes of blood transfusion in surgery
-
Shander, A. (2004). Emerging risks and outcomes of blood transfusion in surgery. Seminars in Hematology, 41(1, Suppl. 1), 117-124.
-
(2004)
Seminars in Hematology
, vol.41
, Issue.1 and SUPPL. 1
, pp. 117-124
-
-
Shander, A.1
-
33
-
-
29544449813
-
Determinants of futility of administration of recombinant factor VIIa in trauma
-
Stein, D. M., Dutton, R. P., O'Connor, J., Alexander, M., & Scalea, T. M. (2005). Determinants of futility of administration of recombinant factor VIIa in trauma. Journal of Trauma, 59(3), 609-615.
-
(2005)
Journal of Trauma
, vol.59
, Issue.3
, pp. 609-615
-
-
Stein, D.M.1
Dutton, R.P.2
O'Connor, J.3
Alexander, M.4
Scalea, T.M.5
-
34
-
-
19944389258
-
The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma
-
Udy, A., Vaghela, M., Lawton, G., & Sigston, P. (2005). The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma. Anaesthesia, 60(6), 613-616.
-
(2005)
Anaesthesia
, vol.60
, Issue.6
, pp. 613-616
-
-
Udy, A.1
Vaghela, M.2
Lawton, G.3
Sigston, P.4
-
35
-
-
0032776024
-
Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: Effect of the length of storage of transfused red cells
-
Vamvakas, E. C., & Carven, J. H. (1999). Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: Effect of the length of storage of transfused red cells. Transfusion, 39(7), 701-710.
-
(1999)
Transfusion
, vol.39
, Issue.7
, pp. 701-710
-
-
Vamvakas, E.C.1
Carven, J.H.2
-
36
-
-
0036686721
-
Massive transfusion exceeding 50 units of blood products in trauma patients
-
discussion 295-296
-
Vaslef, S. N., Knudsen, N. W., Neligan, P. J., & Sebastian, M. W. (2002). Massive transfusion exceeding 50 units of blood products in trauma patients. Journal of Trauma, 53(2), 291-295; discussion 295-296.
-
(2002)
Journal of Trauma
, vol.53
, Issue.2
, pp. 291-295
-
-
Vaslef, S.N.1
Knudsen, N.W.2
Neligan, P.J.3
Sebastian, M.W.4
|